ABSTRACT In this study, we tested the hypothesis that myocardial ischemia induced by exercise in patients is associated with diminished metabolism and/or delayed clearance of an intravenously injected fatty acid, iodine 123-labeled phenylpentadecanoic acid (IPPA). Fifteen normal volunteers and 18 patients with significant coronary heart disease (CHD) received IPPA during exercise. In the patients with CHD, radionuclide ventriculograms were also obtained during exercise. The normal volunteers had relatively uniform initial left ventricular segmental IPPA activity after exercise and uniform IPPA clearance in the interval from 4 to 20 min immediately after exercise. In contrast, the patients with CHD had increased initial left ventricular segmental IPPA activity (63%, p < .001) and delayed IPPA clearance (44%, p < .01) in segments supplied by significantly narrowed coronary arteries. Based on analysis with the mean values + 1 SD for initial IPPA activity, clearance, or both in normal volunteers, the sensitivity and specificity of exercise IPPA scintigraphy for detecting CHD were 89% and 67%, respectively; when + 2 SD differences from the mean values in the normal volunteers were considered, the sensitivity and specificity were 72% and 100%, respectively. Among the total of 27 noninfarcted left ventricular segments supplied by significantly narrowed coronary arteries in the study patients, 26 (96%) had an abnormality (mean + 1 SD) of either initial IPPA activity or clearance compared with corresponding segments in the normal volunteers and/or with other left ventricular segments in the same image that were not supplied by significantly narrowed coronary arteries. Thus, these data suggest that IPPA scintigraphy may be used in the identification of myocardial ischemia in patients with CHD by demonstrating abnormal initial left ventricular segmental IPPA activity and/or delayed clearance after exercise. Circulation 74, No. 5, 1007No. 5, -1015No. 5, , 1986 
UNDER AEROBIC and fasting conditions, free fatty acids are the preferred substrate of normal myocardium, providing up to 90% of resting energy requirements." 2 Therefore, radiolabeled fatty acids have attracted great interest for cardiac imaging and as potential probes of myocardial metabolism. Studies by Sobel, Schelbert, and Weiss and their colleagues and others using "C-palmitate with positron tomography have shown great promise for this technique in defin-ing ischemic and infarcted myocardium.3 -1 However, such studies require a cyclotron to produce short-lived radioisotopes as well as specialized imaging systems. Thus, these methods are expensive and not presently available for routine clinical use at most institutions.
Several fatty acids, including hexadecanoic and heptadecanoic acids, have been synthesized and labeled with single photon-emitting radioisotopes. [12] [13] [14] [15] [16] [17] [18] Modifications of fatty acid chain length,19 degree of methylation,20 or incorporation of metallic heteroatoms such as tellurium21-23 have been attempted to alter myocardial uptake or metabolism. In some instances, however, interpretation of the myocardial kinetics of these agents has been hampered by poor image contrast due to release of free radioiodine by the myocardium and by hepatic ,B-oxidation. Freundlieb et al."8 have proposed correction procedures for identify-ing the free 123J activity not specifically bound to myocardial cells, but an iodine-labeled fatty acid that is metabolized without liberation of free radioiodine is desirable.
Recently, Machulla et al. 24 synthesized o-(p-I-123 phenyl)-pentadecanoic acid (IPPA), a long-chain free fatty acid that undergoes /3-oxidation without significant deiodination. The chemical structure of IPPA is 1231e--(CH2)14-COOH. In our laboratory, Kulkarni et al. 25 have modified the synthesis of IPPA with improved radiochemical yields of greater than 90%, thus enhancing its utility in human imaging. 25 Chien and Reske and their colleagues have shown rapid myocardial uptake of IPPA and biexponential clearance similar to that of 3H-palmitate in animal preparations.26 27 IPPA is metabolized to iodobenzoic acid with subsequent rapid renal excretion.26 ' 27 Using single photonemission tomography or computed tomographic imaging, we have also previously demonstrated that acutely infarcted canine myocardium shows decreased uptake and/or delayed clearance of IPPA, even when coronary blood flow is restored by reperfusion. 28 The goal of the present study was to characterize the uptake and clearance of IPPA at rest and during exercise in normal volunteers and patients with coronary heart disease. In these studies, we tested the hypothesis that regions of myocardial ischemia exhibit diminished metabolism and/or delayed clearance of intravenously injected IPPA, thus allowing detection of ischemic regions as areas of increased IPPA activity on myocardial scintigraphic images. Planar imaging was performed with a standard-field-of-view gamma camera (Picker Dyna Mo) equipped with a generalpurpose, low-energy, parallel-hole collimator interfaced to a dedicated nuclear medicine computer for data acquisition, storage, and analysis (Technicare 560, Solon, OH). Energy discrimination was provided by a 20% window centered on the 159 keV photopeak of 1231. Images were acquired in a 40 degree left anterior oblique projection. Individual images of 4 min duration were acquired with a digital resolution of 128 x 128 beginning at 4, 20, 40, and 60 to 90 min after IPPA injection. Count densities in normal left ventricular segments before background subtraction averaged 80 counts/pixel.
Methods
Quantitation of myocardial IPPA activity. Images were aligned and spatially smoothed. Background activity was measured in a region of interest constructed two to three pixels outside the left ventricular boundary and adjacent to the apicallateral segment of the left ventricle. Left ventricular regions of interest were constructed over the high or basal-septal, low or apical-septal, low or apical-lateral, and high or basal-lateral segments of each image (figure 1). The left ventricular apex was avoided to minimize confusion due to normal thinning of the left ventricular muscle mass in that region. IPPA activity in segments 1 and 2 was assumed to reflect the distribution of the left anterior descending coronary artery (LAD), that in segment 3 the right coronary artery (RCA), and that in segment 4 the left circumflex coronary artery (LCX). Activity within each region was normalized to the mean activity of all segments within the image. Segmental washout rates were calculated from the mean activity in each segment before normalization. IPPA were performed for statistical comparisons (p < .05 was considered indicative of a statistically significant difference).32 Abnormal left ventricular segments were those in which there was a 1 SD increase or decrease in segmental IPPA activity or clearance compared with that in corresponding left ventricular segments of normal volunteers. Values for left ventricular segmental clearance more than 1 SD different from the maximal mean values in normally perfused segments within the same image were also considered abnormal.
Results
Consequences of administration of IPPA. No changes in resting heart rate, respiratory rate, or blood pressure were recorded after the intravenous injection of IPPA. Administration of Lugol's solution resulted in nearcomplete suppression of thyroid uptake of radioactivity in all subjects studied.
Normal volunteers Exercise responses. Six normal volunteers underwent exercise radionuclide ventriculography. They exercised to a mean workload of 942 + 307 kp-m, a mean heart rate of 142 ± 18 beats/min, and a mean systolic blood pressure of 184 ± 29 mm Hg. None of the normal volunteers developed chest pain or ST segment alterations suggestive of ischemia with exercise. All volunteers had the expected normal increase in global LVEF, decrease in left ventricular end-systolic volume index, and lack of deterioration in left ventricular segmental motion.
During the exercise IPPA examination, the volunteers exercised to a mean workload of 936 ± 221 kp-m, a mean heart rate of 166 ± 25 beats/min, and a mean systolic blood pressure of 183 ± 19 mm Hg.
IPPA images. Initial IPPA activity in normal volunteers (figure 2) was relatively uniform, with the mean maximal difference in left ventricular segmental activity varying by 18 ± 7% at rest and 13 ± 5% after exercise ( IPPA images. Although most IPPA studies demonstrated clear abnormalities that could be appreciated visually, quantitative analyses were required to detect abnormalities in approximately 30% of patients studied. Figures 3 and 4 are IPPA images that illustrate the left ventricular segmental heterogeneity of IPPA activity at rest and immediately after exercise in two patients. The maximal differences in left ventricular segmental activity averaged 36% and 30% at rest and after exercise, respectively (p < .001; table 3).
The sensitivity and specificity of exercise IPPA scintigraphy for the detection of coronary heart disease were determined by comparing the variation in initial left ventricular IPPA activity and/or clearance on the patients' images with those on images of the normal volunteers (table 4) . Based on analysis with the mean normal values ± 2 SD for initial left ventricular segmental IPPA activity, clearance, or both, the sensitivity of IPPA scintigraphy for detecting coronary heart disease was 67%, 22%, and 72%, respectively. The specificity was 100% when alterations in initial IPPA activity, clearance, or both were considered. When the mean normal values ± ] SD were considered, the sensitivity increased to 89%, 39%, and 89%, respectively, and the specificity fell to 78%, 89%, and 67%, respectively. Color code is as in figure 2 .
In the patients studied during exercise, there were 27 coronary arteries with stenoses of 70% or more supplying noninfarcted myocardium (12 LAD, six RCA, and nine LCX). Compared with the left ventricular segmental IPPA distribution in the normal volunteers, in the patients initial IPPA activity in left ventricular regions supplied by significant coronary stenoses was increased in 17 of 27 patients (63% of the total), it was normal in seven of 27 (26%), and it decreased in three of 27 (11%) (p < .001; table 5). One patient with severe three-vessel coronary arterial stenoses without prior infarction had homogeneous activity in all segments and they were not classified as abnormal by our distribution criteria. However, this patient had markedly delayed IPPA washout in all left ventricular segments. AChange from rest to exercise in left ventricular end-systolic volume index (ml).
BCoronary arteriographic findings before CABG (IPPA study was performed after CABG 
Discussion
In the present study, we used resting and postexercise IPPA myocardial scintigraphy in normal volunteers and patients with known coronary heart disease to test the hypothesis that left ventricular myocardium supplied by significantly stenosed coronary arteries exhibits abnormal initial IPPA uptake and/or metabolism or delayed clearance that can be detected by this method. The left ventricular segmental uptake and washout of IPPA was relatively uniform in normal volunteers, and our more recent studies have also demonstrated that submaximal exercise in normal volunteers does not cause reduced left ventricular segmental IPPA uptake or clearance. In contrast, myocardial segments supplied by significantly narrowed coronary CIRCULATION reductions in flow may decrease myocardial uptake or retention of fatty acids, possibly by reducing the activity of the enzyme acyl-CoA synthetase. Free fatty acid and CoA are substrates for acyl-CoA synthetase, and the acyl-CoA product is sequestered in the cell. If administered free fatty acid is not transformed into an acyl-CoA derivative, it may diffuse out of the myocardial cell. 4 7 The early phase of IPPA metabolism and clearance is similar to that observed with "C-palmitate, with a half-life of 3.0 to 6.5 min,26 27 and almost certainly represents direct oxidation of IPPA rather than delayed incorporation into triglyceride stores. The early phase of free fatty acid oxidation has been demonstrated to be diminished in magnitude and prolonged in duration in regions of myocardial ischemia.4'9 16 Since our first scintigrams were acquired between 4 and 8 min after injection of contrast, significant direct oxidation of fatty acid had already occurred, especially in the normally perfused segments. Therefore, the initial IPPA activity we measured reflected both segmental myocardial uptake and early washout of the IPPA that had already undergone direct oxidation. Thus, in ischemic myocardial segments, the relatively increased segmental IPPA activity we measured in some patients was most likely caused by a combination of decreased direct oxidation of IPPA and enhanced IPPA extraction. Miller et al.33 also found increased activity of radioiodinated fatty acid in the ischemic "border zone" left ventricular segments using a canine preparation of temporary coronary arterial occlusion and reperfusion. Although our findings with IPPA myocardial scintigraphy in normal volunteers and patients with coronary heart disease are encouraging, there are several factors that may have reduced the accuracy of our measurement of left ventricular segmental IPPA activity as well as the overall sensitivity for detection of abnormalities in the early distribution or clearance of IPPA in the left ventricular segments that were studied. All of the patients with coronary heart disease were treated with their individual maximal doses of antianginal medications, which would delay or prevent the development of myocardial ischemia with exercise and therefore attenuate ischemic alterations in fatty acid metabolism. In addition, we used planar imaging in a single projection. We anticipate that our ability to detect myocardial ischemia as a regional area of relatively increased IPPA activity using scintigraphy will be substantially improved when patients are evaluated before institution of aggressive medical therapy and with tomographic imaging.
In the analysis of the scintigrams from the patients, we classified as abnormal IPPA activity or clearance values that deviated by more than 1 SD from the mean left ventricular segmental values in normal volunteers. Using these criteria, we were able to identify regions of abnormal IPPA initial activity or clearance. As our number of normal volunteers increases in future studies, we anticipate that our range of normality will decrease and the use of the mean ± 2 SD may be feasible to define a normal range. In fact, the sensitivity and specificity of exercise IPPA scintigraphy for the detection of coronary heart disease with the use of the mean variation in initial IPPA activity and/or clearance ± 2 SD in normal volunteers were 72% and 100%, respectively.
Our data suggest that IPPA myocardial scintigraphy identifies regions of myocardial ischemia as areas of increased IPPA activity and/or delayed washout of IPPA compared with those in normally perfused left ventricular segments. In contrast, 207T1 uptake is decreased in ischemic regions. Delayed images obtained 3 to 4 hr after injection are necessary with 201T1l to 1014 distinguish myocardial ischemia from infarction. By providing a marker of ischemia after a relatively brief period of image acquisition, IPPA myocardial scintigraphy potentially provides an efficient means of detecting segmental ischemia. However, in the future, direct comparison studies with 201TI scintigraphy will be necessary to evaluate the relative sensitivity and specificity of each diagnostic modality in the noninvasive detection of coronary heart disease.
In conclusion, IPPA scintigraphy generally provides high-quality myocardial images that appear to reflect the metabolic integrity and/or perfusion of normal and ischemic myocardium. Exercise IPPA scintigraphy may allow the identification of myocardial ischemia as regions of relatively increased IPPA activity, thus allowing the noninvasive detection of segmental metabolic abnormalities associated with severe coronary heart disease.
